Nakajima Yuki, Iijima Yoshihito, Kinoshita Hiroyasu, Akiyama Hirohiko, Beppu Takeshi, Uramoto Hidetaka, Hirata Tomomi
Division of Thoracic Surgery, Saitama Cancer Center, Kitaadachi-gun, Saitama, Japan.
Division of Head and Neck Surgery, Saitama Cancer Center, Kitaadachi-gun, Saitama, Japan.
Ann Thorac Cardiovasc Surg. 2017 Aug 20;23(4):169-174. doi: 10.5761/atcs.oa.16-00269. Epub 2017 May 9.
Although the number of surgeries performed for pulmonary metastasis of head and neck cancer has been increasing, there have been few reports of the surgical effectiveness. We collected the data of surgeries performed in our facility in order to discuss the surgical performance and indication.
We retrospectively examined the prognosis and predictors for 58 patients with pulmonary metastasis of head and neck cancer who underwent a surgery in our facility during the 15-year period, from January 2000 to December 2015.
The 3-year and 5-year survival rates were 54.2% and 35.7%, respectively, and the median survival time was 42.2 months. The disease-free interval (DFI) was less than 24 months and patients with oral cavity cancer were poor prognostic factors.
The effectiveness of surgical treatment for pulmonary metastasis of head and neck cancer was suggested.
尽管针对头颈部癌肺转移进行的手术数量一直在增加,但关于手术疗效的报道却很少。我们收集了本院进行手术的数据,以便讨论手术操作及适应证。
我们回顾性研究了2000年1月至2015年12月这15年间在本院接受手术的58名头颈部癌肺转移患者的预后及预测因素。
3年和5年生存率分别为54.2%和35.7%,中位生存时间为42.2个月。无病生存期(DFI)小于24个月以及口腔癌患者是预后不良因素。
提示了手术治疗头颈部癌肺转移的有效性。